We are live on
!
Find out more
GC
Globeflex Capital Portfolio holdings
AUM
$783M
1-Year Est. Return
81.58%
This Fund
S&P 500
This Quarter
Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
(+18%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-2.82%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$6.96M |
| 2 |
MYR Group
MYRG
|
+$4.57M |
| 3 |
Leonardo DRS
DRS
|
+$4.16M |
| 4 |
Semtech
SMTC
|
+$3.99M |
| 5 |
P
Everpure Inc
P
|
+$3.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$11.2M |
| 2 |
Credicorp
BAP
|
+$9.17M |
| 3 |
Nextpower Inc. Common Stock
NXT
|
+$6.93M |
| 4 |
XP
XP
|
+$6.54M |
| 5 |
Sterling Infrastructure
STRL
|
+$5.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.29% |
| 2 | Industrials | 19.78% |
| 3 | Financials | 17.73% |
| 4 | Healthcare | 17.14% |
| 5 | Consumer Discretionary | 7.28% |
No holdings matched the selected filter criteria.
Similar funds
CC
CCG
LF
LF
TWM
SFWA
WC
CWP
Globeflex Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.
- Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
- Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
- Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
- Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
- Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
- Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
- Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.
Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.